Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Z Gao; J Golob; V M Tanavde; C I Civin; R G Hawley; L Cheng (Profiled Authors: Curt Civin; Linzhao Cheng)
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
Stem cells (Dayton, Ohio) 2001;19(3):247-59.
Both oncoretroviral and lentiviral vectors have been shown to transduce CD34(+) human hematopoietic stem cells (HSC) capable of establishing human hematopoiesis in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice that support partially human hematopoiesis. We and others have reported that murine stem cell virus (MSCV)-based oncoretroviral vectors efficiently transduced HSC that had been cultured ex vivo for 4-7 days with cytokines, resulting in transgene expression in lymphoid and myeloid progenies of SCID-engrafting cells 4-8 weeks post-transplantation. Although lentiviral vectors have been demonstrated to transduce HSC under minimal ex vivo culture conditions, concerns exist regarding the level of transgene expression mediated by these vectors. We therefore evaluated a novel hybrid lentiviral vector (GIN-MU3), in which the U3 region of the HIV-1 long terminal repeat was replaced by the MSCV U3 region (MU3). Human cord blood CD34(+) cells were transduced with vesicular stomatitis virus G envelope protein-pseudotyped lentiviruses during a 48-hour culture period. After a total of 4 days in culture, transduced cells were transplanted into NOD/SCID mice to examine gene transfer and expression in engrafting human cells. Fifteen weeks post-transplantation, 37% +/- 12% of engrafted human cells expressed the green fluorescence protein (GFP) gene introduced by the lentiviral vector. High levels of GFP expression were observed in lymphoid, myeloid and erythroid progenies, and in engrafted human cells that retained the CD34(+) phenotype 15 weeks post-transplantation. This study provides evidence that lentiviral vectors transduced both short-term and long-term engrafting human cells, and mediated persistent transgene expression at high levels in multiple lineages of hematopoietic cells.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2003Xiaobing Yu; Xiangcan Zhan; Jenice D'Costa; Vivek M Tanavde; Zhaohui Ye; Tien Peng; Matthew T Malehorn; Xiaoming Yang; Curt I Civin; Linzhao Cheng
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(6):827-38. -
2.
2000J D Mosca; J K Hendricks; D Buyaner; J Davis-Sproul; L C Chuang; M K Majumdar; R Chopra; F Barry; M Murphy; M A Thiede; et al.
Mesenchymal stem cells as vehicles for gene delivery.
Clinical orthopaedics and related research 2000;(379 Suppl):S71-90. -
3.
2002Yan Cui; Jonathan Golob; Erin Kelleher; Zhaohui Ye; Drew Pardoll; Linzhao Cheng
Blood 2002;99(2):399-408.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
92









-
212









-
926









-
25









-
255









-
74










